| 注册

重构本草之猫爪草

周凌 罗金丽 胡东森 胡诗宛 张伟 赵林华

长春中医药大学学报2026,Vol.42Issue(9):1048-1050,3.
✕
长春中医药大学学报2026,Vol.42Issue(9):1048-1050,3.DOI:10.13463/j.cnki.cczyy.2026.09.009

重构本草之猫爪草

Reconstruction of Chinese materia medica:Ranunculi Ternati Radix

周凌 1罗金丽 2胡东森 3胡诗宛 3张伟 4赵林华5

作者信息

  • 1. 成都中医药大学,成都 610075||中国中医科学院广安门医院,北京 100053
  • 2. 广东一方制药有限公司,广东 佛山 528244
  • 3. 中国中医科学院广安门医院,北京 100053||北京中医药大学,北京 100029
  • 4. 甘肃中医药大学基础医学院,兰州 730000
  • 5. 中国中医科学院广安门医院,北京 100053
  • 折叠

摘要

Abstract

Through investigation of ancient books and the sorting of modern research achievements of traditional Chinese medicine,combined with the understanding and application experience of famous experts and scholars in disciplinary fields such as traditional Chinese medicine clinical medicine and science of Chinese materia medica,it is concluded that Ranunculi Ternati Radix mainly has the e ffects of resolving phlegm and dissipating nodules,detoxifying and reducing swelling.Biochemical indicator targets are thyroid nodules with goiter,lung tumors,and lymph node masses.Modern pharmacological studies have found that Ranunculi Ternati Radix and its active components have the effects of antitumor,immunomodulatory,and anti-inflammatory.No obvious toxic side effects are observed in the toxicity test of the aqueous extract of Ranunculi Ternati Radix.The commonly used clinical dosage is 8-30 g.

关键词

猫爪草/重构本草/临床回归

Key words

Ranunculi Ternati Radix/biochemical indicator target/reconstruction of Chinese materia medica/clinical verification

分类

医药卫生

引用本文复制引用

周凌,罗金丽,胡东森,胡诗宛,张伟,赵林华..重构本草之猫爪草[J].长春中医药大学学报,2026,42(9):1048-1050,3.

基金项目

国家自然科学基金委员会-中国科学院联合项目资助中西医结合创新范式战略研究(XK2023SMC003) (XK2023SMC003)

长春中医药大学学报

2095-6258

访问量0
|
下载量0
段落导航相关论文